GGrantIndex
← Leaderboards

Lawrence S Goldstein

University Of California San Diego

Google Scholar ↗PubMed ↗ORCID ↗
$14,729,706
Attributed
$19,852,900
Total exposure
14
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY2005–22
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$19,852,900 · 14

By mechanism

U01$4,648,205 · 1
R01$4,364,867 · 2
RF1$1,936,014 · 1
R44$1,874,535 · 1
U19$1,775,021 · 1
P30$1,104,779 · 1

Top collaborators

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposBaseInduced Pluripotent Stem CellS DiseaseNeuronsGeneticSignal TransductionTechnologyCellsCell LineCell ModelResearch PersonnelVariantS Disease ModelPhenotypeGenomicsPathway InteractionsGenerationsCollaborationsGenomeAmyloid Precursor Protein ProcessingIn VivoPathologyNeuropathology

Grant awards (54)

iPSC$241,265
P30 · FY2022 · AG · contact PI
iPSC$286,796
P30 · FY2021 · AG · contact PI
iPSC$278,661
P30 · FY2020 · AG · contact PI
Scalable technologies for genome engineering in hIPSCs$408,610
U19 · FY2019 · MH · contact PI
iPSC$298,057
P30 · FY2019 · AG · contact PI
Scalable technologies for genome engineering in hIPSCs$408,610
U19 · FY2018 · MH · contact PI
Probing SORL1 Risk Factors with Human Induced Pluripotent Stem Cell Technology$165,547
P50 · FY2018 · AG · contact PI
Probing the molecular and cellular complexity of APP trafficking and its relationship to AD.$582,310
R56 · FY2017 · AG · contact PI
Scalable technologies for genome engineering in hIPSCs$306,948
U19 · FY2017 · MH · contact PI
Probing SORL1 Risk Factors with Human Induced Pluripotent Stem Cell Technology$165,609
P50 · FY2017 · AG · contact PI
Lab-on-a-chip Flow Cytometer Using COlor-Space-Time (COST) Coding Method$598,206
R44 · FY2016 · GM
Scalable technologies for genome engineering in hIPSCs$306,948
U19 · FY2016 · MH · contact PI
Probing SORL1 Risk Factors with Human Induced Pluripotent Stem Cell Technology$157,499
P50 · FY2016 · AG · contact PI
Lab-on-a-chip Flow Cytometer Using COlor-Space-Time (COST) Coding Method$659,341
R44 · FY2015 · GM
Scalable technologies for genome engineering in hIPSCs$343,905
U19 · FY2015 · MH · contact PI
Probing SORL1 Risk Factors with Human Induced Pluripotent Stem Cell Technology$153,667
P50 · FY2015 · AG · contact PI
Lab-on-a-chip Flow Cytometer Using COlor-Space-Time (COST) Coding Method$17,158
R44 · FY2015 · GM
Elucidating AD genotype-phenotype relationships using genetics of human IPS cells$1,936,014
RF1 · FY2014 · AG · contact PI
Lab-on-a-chip Flow Cytometer Using COlor-Space-Time (COST) Coding Method$599,830
R44 · FY2014 · GM
Probing SORL1 Risk Factors with Human Induced Pluripotent Stem Cell Technology$157,500
P50 · FY2014 · AG · contact PI
REGULATORY GENOMIC STUDIES IN A COHORT OF IPS CELL DERIVED CARDIOMYOCYTES$2,405,595
U01 · FY2013 · HL
Testing cell autonomy of AD phenotypes using human IPS cells$213,834
R21 · FY2013 · NS · contact PI
REGULATORY GENOMIC STUDIES IN A COHORT OF IPS CELL DERIVED CARDIOMYOCYTES$1,403,130
U01 · FY2012 · HL
Testing cell autonomy of AD phenotypes using human IPS cells$183,920
R21 · FY2012 · NS · contact PI
Pluripotent stem cell models of sporadic Alzheimer's Disease$183,617
R21 · FY2012 · AG · contact PI
REGULATORY GENOMIC STUDIES IN A COHORT OF IPS CELL DERIVED CARDIOMYOCYTES$72,560
U01 · FY2012 · HL
REGULATORY GENOMIC STUDIES IN A COHORT OF IPS CELL DERIVED CARDIOMYOCYTES$766,920
U01 · FY2011 · HL
Impairment of axonal transport by Amyloid precursor protein and amyloid Beta-prot$332,435
R01 · FY2011 · AG · contact PI
Pluripotent stem cell models of sporadic Alzheimer's Disease$152,026
R21 · FY2011 · AG · contact PI
Human Stem Cell Model of Niemann Pick Type C$1,000,000
RC1 · FY2010 · NS · contact PI
Impairment of axonal transport by Amyloid precursor protein and amyloid Beta-prot$335,783
R01 · FY2010 · AG · contact PI
Impairment of axonal transport by Amyloid precursor protein and amyloid Beta-prot$329,297
R01 · FY2009 · AG · contact PI
Impairment of axonal transport by Amyloid precursor protein and amyloid Beta-prot$319,702
R01 · FY2008 · AG · contact PI
Impairment of axonal transport by Amyloid precursor protein and amyloid Beta-prot$316,725
R01 · FY2007 · AG · contact PI
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$333,963
R01 · FY2006 · GM · contact PI
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$111,322
R01 · FY2006 · GM · contact PI
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$396,760
R01 · FY2005 · GM
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$114,000
R01 · FY2005 · GM
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$8,466
R01 · FY2005 · GM
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$342,000
R01 · FY2004 · GM
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$114,000
R01 · FY2004 · GM
Genetic Analysis of Dendritic Targeting$32,000
R03 · FY2004 · TW
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$27,832
R01 · FY2004 · GM
Genetic Analysis of Dendritic Targeting$4,500
R03 · FY2004 · TW
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$342,000
R01 · FY2003 · GM
Genetic Analysis of Dendritic Targeting$33,560
R03 · FY2003 · TW
TRAINING PROGRAM IN BASIC AND CLINICAL GENETICS$295,680
T32 · FY2002 · GM
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$291,435
R01 · FY2002 · GM
Genetic Analysis of Dendritic Targeting$34,000
R03 · FY2002 · TW
TRAINING PROGRAM IN BASIC AND CLINICAL GENETICS$326,436
T32 · FY2001 · GM
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$283,034
R01 · FY2001 · GM
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$314,813
R01 · FY2000 · GM
TRAINING PROGRAM IN BASIC AND CLINICAL GENETICS$307,774
T32 · FY2000 · GM
GENETIC AND IMMUNOLOGIC ANALYSIS OF MICROTUBULE PROTEINS$51,300
R01 · FY2000 · GM